We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFIS icon
3751
Peoples Financial Services
PFIS
$717M
$13.6K ﹤0.01%
311
-227
-42% -$9.24K
FNKO icon
3752
Funko
FNKO
$335M
$13.6K ﹤0.01%
1,258
+451
+56% +$4.96K
SLDP icon
3753
Solid Power
SLDP
$545M
$13.6K ﹤0.01%
5,358
+327
+6% +$755
ECOR icon
3754
electroCore
ECOR
$89.6M
$13.6K ﹤0.01%
2,776
+189
+7% +$1.03K
ANNX icon
3755
Annexon
ANNX
$862M
$13.6K ﹤0.01%
3,858
-4,134
-52% -$18.1K
RPT
3756
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$13.6K ﹤0.01%
1,299
-1,637
-56% -$15.5K
FRG
3757
DELISTED
Franchise Group, Inc.
FRG
$13.5K ﹤0.01%
473
-2,017
-81% -$57.8K
CSTL icon
3758
Castle Biosciences
CSTL
$933M
$13.5K ﹤0.01%
987
+362
+58% +$7.33K
NRXP icon
3759
NRX Pharmaceuticals
NRXP
$143M
$13.5K ﹤0.01%
2,794
+1,310
+88% +$7.88K
BRBS icon
3760
Blue Ridge Bankshares
BRBS
$336M
$13.5K ﹤0.01%
1,527
-91
-6% -$825
BSJO
3761
DELISTED
Invesco BulletShares 2024 High Yield Corporate Bond ETF
BSJO
$13.5K ﹤0.01%
601
+577
+2,404% +$12.9K
UMC icon
3762
United Microelectronic
UMC
$48.6B
$13.5K ﹤0.01%
1,712
+1,282
+298% +$10.6K
RNAC icon
3763
Cartesian Therapeutics
RNAC
$264M
$13.5K ﹤0.01%
402
-346
-46% -$12.4K
NATR icon
3764
Nature's Sunshine
NATR
$269M
$13.5K ﹤0.01%
988
-110
-10% -$1.25K
OMQS
3765
DELISTED
OMNIQ Corp. Common Stock
OMQS
$13.4K ﹤0.01%
3,329
+2,377
+250% +$12K
VIP
3766
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$33.5M
$13.4K ﹤0.01%
4,763
+2,569
+117% +$9.69K
HTB
3767
HomeTrust Bancshares
HTB
$837M
$13.4K ﹤0.01%
643
+39
+6% +$829
SLGL icon
3768
Sol-Gel Technologies
SLGL
$275M
$13.4K ﹤0.01%
449
-26
-5% -$910
SY
3769
So-Young International
SY
$221M
$13.4K ﹤0.01%
7,299
-3,427
-32% -$8.21K
GIFI
3770
DELISTED
Gulf Island Fabrication
GIFI
$13.4K ﹤0.01%
4,131
-169
-4% -$572
PKBK icon
3771
Parke Bancorp
PKBK
$413M
$13.4K ﹤0.01%
790
-12
-1% -$201
ASTL icon
3772
Algoma Steel
ASTL
$471M
$13.4K ﹤0.01%
1,890
+1,747
+1,222% +$13K
COCP icon
3773
Cocrystal Pharma
COCP
$15.2M
$13.4K ﹤0.01%
5,613
-3,038
-35% -$7.38K
HTBK
3774
DELISTED
Heritage Commerce
HTBK
$13.4K ﹤0.01%
1,620
-739
-31% -$5.86K
IPAY icon
3775
Amplify Mobile Payments ETF
IPAY
$188M
$13.4K ﹤0.01%
314

Similar funds

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.